RANZCR examiner reports · fix it Missing the detail in the stem Skipping the age, medicine, allergy or setting that changes the answer.
What it looks like: One line in the stem (a current medicine, pregnancy, kidney function, an allergy, a rural setting) makes the usual answer wrong. Reading for the diagnosis and skimming the rest misses it.
How to fix it: Before answering, list the patient's medicines, conditions and setting from the stem. For each option you like, check it against that list for interactions and contraindications.
The drill: 15 questions Questions from the Radiology bank picked because they test this habit. You answer one at a time and see the explanation straight away.
The first 3 are free, below and in the drill with a free account. Any Radiology plan opens all 15.
Try 3 now. No account needed. Question 1 of 3 Neuroradiology
A 64-year-old woman wakes with right hemiparesis and aphasia; she was last seen well 9 hours earlier when she went to bed. CT angiography shows no large vessel occlusion, and CT perfusion is not available. MRI shows an acute left frontal infarct that is bright on diffusion-weighted images with low ADC, but with no corresponding signal change on FLAIR. She has no contraindication to thrombolysis. How should the MRI findings guide treatment? A Withhold thrombolysis, as she was last seen well 9 hours ago B Thrombectomy, as the DWI lesion is still small C Thrombolysis, as onset was probably within 4.5 hours D Aspirin, as the DWI lesion is already irreversible E No reperfusion, as FLAIR is needed to confirm infarction
Pick an answer to see the explanation. Next question →
Question 1 of 3 · Neuroradiology
A 64-year-old woman wakes with right hemiparesis and aphasia; she was last seen well 9 hours earlier when she went to bed. CT angiography shows no large vessel occlusion, and CT perfusion is not available. MRI shows an acute left frontal infarct that is bright on diffusion-weighted images with low ADC, but with no corresponding signal change on FLAIR. She has no contraindication to thrombolysis. How should the MRI findings guide treatment?
Withhold thrombolysis, as she was last seen well 9 hours ago Thrombectomy, as the DWI lesion is still small Thrombolysis, as onset was probably within 4.5 hours Aspirin, as the DWI lesion is already irreversible No reperfusion, as FLAIR is needed to confirm infarction Show the answer C. Thrombolysis, as onset was probably within 4.5 hours
Diffusion restriction appears within minutes of ischaemia, whereas FLAIR hyperintensity develops over roughly 4.5 to 6 hours. A diffusion lesion without matching FLAIR change (DWI-FLAIR mismatch) therefore identifies a stroke that probably began within about 4.5 hours. In the WAKE-UP trial, patients with wake-up or unknown-onset stroke selected by this mismatch had better functional outcomes with intravenous alteplase. Without a large vessel occlusion, intravenous thrombolysis is the reperfusion option.
Why not A: Time since last seen well overestimates the onset time in wake-up stroke; DWI-FLAIR mismatch allows thrombolysis despite the 9-hour interval. Why not B: Thrombectomy needs a large vessel occlusion, which CT angiography has excluded. Why not D: Aspirin alone would forgo thrombolysis that improves outcomes in this mismatch-selected group; diffusion lesions are not always irreversible. Why not E: FLAIR change is what is absent in the mismatch pattern; waiting for it would mean the stroke had passed the window for thrombolysis. Question 2 of 3 · Interventional & vascular
A 62-year-old man with hepatitis C cirrhosis (Child-Pugh A6, ECOG 0) has a 6 cm hepatocellular carcinoma in the right lobe. CT shows enhancing tumour thrombus extending into the right portal vein and the main portal vein, with no extrahepatic disease. Which treatment is most appropriate?
Orthotopic liver transplantation Best supportive care only Microwave ablation of the tumour and the adjacent portal vein thrombus Systemic atezolizumab plus bevacizumab after variceal screening Conventional transarterial chemoembolisation of the right lobe Show the answer D. Systemic atezolizumab plus bevacizumab after variceal screening
Macrovascular (portal vein) invasion places this patient in Barcelona Clinic Liver Cancer stage C. With Child-Pugh A function and ECOG 0, first-line systemic therapy is recommended; atezolizumab plus bevacizumab is a standard first-line option, with endoscopic variceal assessment and treatment first because of bevacizumab bleeding risk. Conventional TACE is contraindicated with main portal vein tumour thrombus. Ablation and transplantation are for early-stage disease without vascular invasion, and supportive care alone is for terminal stage disease. References: BCLC prognosis and treatment strategy (2022 update); eviQ hepatocellular carcinoma treatment protocols.
Why not A: Macrovascular invasion is outside transplant criteria because of very high recurrence rates. Why not B: With preserved liver function and good performance status, active systemic therapy improves survival. Why not C: Ablation suits small tumours of 3 cm or less without vascular invasion. Why not E: Main portal vein invasion is a contraindication to conventional TACE because of the risk of hepatic infarction. Question 3 of 3 · Physics, imaging technology & radiation safety
A 58-year-old woman with hypertension taking metoprolol has CT of the chest with iodinated contrast. Why does her beta-blocker matter if she develops an anaphylactic reaction?
Beta-blockers cause a delayed rash rather than anaphylaxis Beta-blockers prevent hypotension during anaphylaxis Beta-blockers make adrenaline unnecessary Beta-blockers mean contrast should be withheld Reactions may be more severe and resist adrenaline Show the answer E. Reactions may be more severe and resist adrenaline
Beta-blockers may increase the severity of anaphylaxis and blunt the response to adrenaline, partly by blocking beta-adrenergic effects and allowing unopposed alpha and reflex vagal effects. Adrenaline remains first-line, and glucagon can be considered for refractory hypotension. Beta-blockers do not prevent hypotension, are not a contraindication to contrast, and do not convert anaphylaxis to a delayed rash. References: ASCIA Acute Management of Anaphylaxis Guidelines; RANZCR Iodinated Contrast Guidelines.
Why not A: Beta-blockers do not change the type of reaction to a delayed rash. Why not B: They can worsen hypotension and limit compensation. Why not C: Adrenaline remains first-line treatment for anaphylaxis. Why not D: Beta-blocker use is not a contraindication to contrast. Create a free account to save your results and keep going →
All RANZCR examiner reports →
Fellowship Ready is not affiliated with or endorsed by the RANZCR. Not affiliated with the Royal Australian and New Zealand College of Radiologists (RANZCR).